Oasmia Pharmaceutical AB
(Other OTC/NBB : OASM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc.
MDCOMedicines Company
GWPHGW Pharmaceuticals PLC Sponsored ADR
AMRNAmarin Corporation Plc Sponsored ADR
JAZZJazz Pharmaceuticals Plc
SAGESAGE Therapeutics, Inc.
PRGOPerrigo Co. Plc
PCRXPacira Pharmaceuticals, Inc.
ENDPEndo International Plc
UTHRUnited Therapeutics Corporation
HZNPHorizon Pharma plc
CTLTCatalent Inc
ICPTIntercept Pharmaceuticals, Inc.
AERIAerie Pharmaceuticals, Inc.

Company Profile

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.